Characterising the Subsite Specificity of Urokinase-Type Plasminogen Activator and Tissue-Type Plasminogen Activator using a Sequence-Defined Peptide Aldehyde Library

Choi Yi Li, Simon J de Veer, Ruby H. P. Law, James C. Whisstock, David J. Craik, Joakim E Swedberg

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) are two serine proteases that contribute to initiating fibrinolysis by activating plasminogen. uPA is also an important tumour-associated protease due to its role in extracellular matrix remodelling. Overexpression of uPA has been identified in several different cancers and uPA inhibition has been reported as a promising therapeutic strategy. Although several peptide-based uPA inhibitors have been developed, the extent to which uPA tolerates different tetrapeptide sequences that span the P1–P4 positions remains to be thoroughly explored. In this study, we screened a sequence-defined peptide aldehyde library against uPA and tPA. Preferred sequences from the library screen yielded potent inhibitors for uPA, led by Ac-GTAR-H (Ki=18 nm), but not for tPA. Additionally, synthetic peptide substrates corresponding to preferred inhibitor sequences were cleaved with high catalytic efficiency by uPA but not by tPA. These findings provide new insights into the binding specificity of uPA and tPA and the relative activity of tetrapeptide inhibitors and substrates against these enzymes.

Original languageEnglish
Pages (from-to)46-50
Number of pages5
JournalChemBioChem
Volume20
Issue number1
DOIs
Publication statusPublished - 2 Jan 2019

Keywords

  • enzymes
  • inhibitors
  • peptides
  • plasminogen activation system
  • serine proteases

Cite this

@article{1f64a499a165441086f666c01798df41,
title = "Characterising the Subsite Specificity of Urokinase-Type Plasminogen Activator and Tissue-Type Plasminogen Activator using a Sequence-Defined Peptide Aldehyde Library",
abstract = "Urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) are two serine proteases that contribute to initiating fibrinolysis by activating plasminogen. uPA is also an important tumour-associated protease due to its role in extracellular matrix remodelling. Overexpression of uPA has been identified in several different cancers and uPA inhibition has been reported as a promising therapeutic strategy. Although several peptide-based uPA inhibitors have been developed, the extent to which uPA tolerates different tetrapeptide sequences that span the P1–P4 positions remains to be thoroughly explored. In this study, we screened a sequence-defined peptide aldehyde library against uPA and tPA. Preferred sequences from the library screen yielded potent inhibitors for uPA, led by Ac-GTAR-H (Ki=18 nm), but not for tPA. Additionally, synthetic peptide substrates corresponding to preferred inhibitor sequences were cleaved with high catalytic efficiency by uPA but not by tPA. These findings provide new insights into the binding specificity of uPA and tPA and the relative activity of tetrapeptide inhibitors and substrates against these enzymes.",
keywords = "enzymes, inhibitors, peptides, plasminogen activation system, serine proteases",
author = "Li, {Choi Yi} and {de Veer}, {Simon J} and Law, {Ruby H. P.} and Whisstock, {James C.} and Craik, {David J.} and Swedberg, {Joakim E}",
year = "2019",
month = "1",
day = "2",
doi = "10.1002/cbic.201800395",
language = "English",
volume = "20",
pages = "46--50",
journal = "ChemBioChem",
issn = "1439-4227",
publisher = "Wiley-VCH Verlag GmbH & Co. KGaA",
number = "1",

}

Characterising the Subsite Specificity of Urokinase-Type Plasminogen Activator and Tissue-Type Plasminogen Activator using a Sequence-Defined Peptide Aldehyde Library. / Li, Choi Yi; de Veer, Simon J; Law, Ruby H. P.; Whisstock, James C.; Craik, David J.; Swedberg, Joakim E.

In: ChemBioChem, Vol. 20, No. 1, 02.01.2019, p. 46-50.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Characterising the Subsite Specificity of Urokinase-Type Plasminogen Activator and Tissue-Type Plasminogen Activator using a Sequence-Defined Peptide Aldehyde Library

AU - Li, Choi Yi

AU - de Veer, Simon J

AU - Law, Ruby H. P.

AU - Whisstock, James C.

AU - Craik, David J.

AU - Swedberg, Joakim E

PY - 2019/1/2

Y1 - 2019/1/2

N2 - Urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) are two serine proteases that contribute to initiating fibrinolysis by activating plasminogen. uPA is also an important tumour-associated protease due to its role in extracellular matrix remodelling. Overexpression of uPA has been identified in several different cancers and uPA inhibition has been reported as a promising therapeutic strategy. Although several peptide-based uPA inhibitors have been developed, the extent to which uPA tolerates different tetrapeptide sequences that span the P1–P4 positions remains to be thoroughly explored. In this study, we screened a sequence-defined peptide aldehyde library against uPA and tPA. Preferred sequences from the library screen yielded potent inhibitors for uPA, led by Ac-GTAR-H (Ki=18 nm), but not for tPA. Additionally, synthetic peptide substrates corresponding to preferred inhibitor sequences were cleaved with high catalytic efficiency by uPA but not by tPA. These findings provide new insights into the binding specificity of uPA and tPA and the relative activity of tetrapeptide inhibitors and substrates against these enzymes.

AB - Urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) are two serine proteases that contribute to initiating fibrinolysis by activating plasminogen. uPA is also an important tumour-associated protease due to its role in extracellular matrix remodelling. Overexpression of uPA has been identified in several different cancers and uPA inhibition has been reported as a promising therapeutic strategy. Although several peptide-based uPA inhibitors have been developed, the extent to which uPA tolerates different tetrapeptide sequences that span the P1–P4 positions remains to be thoroughly explored. In this study, we screened a sequence-defined peptide aldehyde library against uPA and tPA. Preferred sequences from the library screen yielded potent inhibitors for uPA, led by Ac-GTAR-H (Ki=18 nm), but not for tPA. Additionally, synthetic peptide substrates corresponding to preferred inhibitor sequences were cleaved with high catalytic efficiency by uPA but not by tPA. These findings provide new insights into the binding specificity of uPA and tPA and the relative activity of tetrapeptide inhibitors and substrates against these enzymes.

KW - enzymes

KW - inhibitors

KW - peptides

KW - plasminogen activation system

KW - serine proteases

UR - http://www.scopus.com/inward/record.url?scp=85055584159&partnerID=8YFLogxK

U2 - 10.1002/cbic.201800395

DO - 10.1002/cbic.201800395

M3 - Article

VL - 20

SP - 46

EP - 50

JO - ChemBioChem

JF - ChemBioChem

SN - 1439-4227

IS - 1

ER -